FXTAS
- 30 October 2012
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 79 (18), 1898-1907
- https://doi.org/10.1212/wnl.0b013e318271f7ff
Abstract
Objective: Fragile X–associated tremor ataxia syndrome (FXTAS) is defined by FMR1 premutation, cerebellar ataxia, intentional tremor, and middle cerebellar peduncle (MCP) hyperintensities. We delineate the clinical, neurophysiologic, and morphologic characteristics of FXTAS. Methods: Clinical, morphologic (brain MRI, 123I-ioflupane SPECT), and neurophysiologic (tremor recording, nerve conduction studies) study in 22 patients with FXTAS, including 4 women. Results: A total of 43% of patients had no family history of fragile X syndrome (FXS), which contrasts with previous FXTAS series. A total of 86% of patients had tremor and 81% peripheral neuropathy. We identified 3 electroclinical tremor patterns: essential-like (35%), cerebellar (29%), and parkinsonian (12%). Two electrophysiologic patterns evocative of non-length-dependent (56%) and length-dependent sensory neuropathy (25%) were identified. Corpus callosum splenium (CCS) hyperintensity was as frequent (68%) as MCP hyperintensities (64%). Sixty percent of patients had parkinsonism and 47% abnormal 123I-ioflupane SPECT. Unified Parkinson9s Disease Rating Scale motor score was correlated to abnormal 123I-ioflupane SPECT (p = 0.02) and to CGG repeat number (p = 0.0004). Scale for the assessment and rating of ataxia correlated with dentate nuclei hyperintensities (p = 0.03) and CCS hyperintensity was a marker of severe disease progression (p = 0.04). Conclusions: We recommend to include in the FXTAS testing guidelines both CCS hyperintensity and peripheral neuropathy and to consider them as new major radiologic and minor clinical criterion, respectively, for the diagnosis of FXTAS. FXTAS should also be considered in women or when tremor, MCP hyperintensities, or family history of FXS are lacking. Our study broadens the spectrum of tremor, peripheral neuropathy, and MRI abnormalities in FXTAS, hence revealing the need for revised criteria.Keywords
This publication has 41 references indexed in Scilit:
- FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patientsParkinsonism & Related Disorders, 2010
- Ca V 3.1 is a tremor rhythm pacemaker in the inferior oliveProceedings of the National Academy of Sciences of the United States of America, 2010
- Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brainsMovement Disorders, 2009
- Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical managementneurogenetics, 2009
- Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson diseaseParkinsonism & Related Disorders, 2009
- FMR1 CGG repeat length predicts motor dysfunction in premutation carriersNeurology, 2008
- Abnormal Nerve Conduction Features in Fragile X Premutation CarriersArchives of Neurology, 2008
- Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 PremutationAmerican Journal of Human Genetics, 2004
- Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradoxCell, 1991
- Preliminary report: activation of the cerebellum in essential tremorThe Lancet, 1990